Chủ Nhật, 27 tháng 6, 2021
Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support
By BY ABBY GOODNOUGH from NYT Health https://ift.tt/2U6Eboa
via IFTTT Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support Overdoses have surged during the pandemic. Now, for the first time, Congress has appropriated funds specifically for programs that distribute clean syringes and other supplies meant to protect users. BY ABBY GOODNOUGH https://ift.tt/2U6Eboa https://ift.tt/3dkO5t1 New York Times Health Health Drug Abuse and Traffic, Coronavirus (2019-nCoV), Addiction (Psychology), Naloxone (Drug), Deaths (Fatalities), Hypodermic Needles and Syringes, Fentanyl, your-feed-healthcare June 27, 2021 at 11:00PM
Đăng ký:
Đăng Nhận xét (Atom)
OId School New Body
$20.00
Turbulence Training 2.0
$27.00
14 Day Rapid Fat Loss Plan
$17.00
The 21 Day Sugar Detox
$67.00
The Fat Burning Chef
$27.00
The 3 Week Diet System
$47.00
6 Minutes to Skinny
$27.00
Truth About Food Ingredients
$17.00
The Carb Nite Solution
$15.99
7 Day Ab Targeted System
$20.00
The E-Factor Diet
$47.00
Fat Diminsher System
$37.00
Turbulence Training 2.0
$27.00
Eat Stop Eat
$20.00
4 Cycle Fat Loss System
$20.00
The Beta Switch
$37.00
5 Day Detox
$7.00
Legal Notice: Product prices and availability are subject to change. Visit corresponding website for more details. Trade marks & images are copyrighted by their respective owners.
Tìm kiếm Blog này
-
By Yarimar Bonilla from NYT Opinion https://ift.tt/O3swUmR via IFTTT Kamala Harris’s Epic Fail in Puerto Rico Yarimar Bonilla While she d...
-
By Michael Wilson from NYT New York https://ift.tt/9EORsbw via IFTTT Music Teacher Is Charged With Taking Teenagers on Trips to Abuse The...
-
By BY FLORENCE FABRICANT from NYT Food https://ift.tt/3btB66X via IFTTT An Uncommon Rise for Bread Jenny Bardwell explains how to salt-ri...
Avengers, Assemble
By Gail Collins and Bret Stephens from NYT Opinion https://ift.tt/9NXJG5H via IFTTT Avengers, Assemble Gail Collins and Bret Stephens All...
Không có nhận xét nào:
Đăng nhận xét